Camden Capital »

iShares NASDAQ Biotechnology Index shares owned by Camden Capital

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $466k 3.4k 135.86
2022-09-30 $511k 4.4k 116.96

More positions owned by Camden Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
General Electric Com New (GE)
New York Community Ban (NYCB)
Citigroup Com New (C)
Micron Technology (MU)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Chevron Corporation (CVX)
Bank of America Corporation (BAC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)

View all positions for Camden Capital

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Elliott Investment Management
Citigroup
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
UBS Group
Citadel Advisors
Royal Bank of Canada
Susquehanna International
Barclays
Commerce Bank N A
Wells Fargo & Company
Main Management ETF Advisors
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding iShares NASDAQ Biotechnology Index